BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Levy JH. Discontinuation and Management of Direct-Acting Anticoagulants for Emergency Procedures. Am J Med 2016;129:S47-53. [PMID: 27569675 DOI: 10.1016/j.amjmed.2016.06.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Lopez CN, Succar L, Varnado S, Donahue KR. Direct Oral to Parenteral Anticoagulants: Strategies for Inpatient Transition. J Clin Pharmacol 2021;61:32-40. [PMID: 32639606 DOI: 10.1002/jcph.1694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Eikelboom J, Merli G. Bleeding with direct oral anticoagulants vs warfarin: clinical experience. Am J Emerg Med 2016;34:3-8. [PMID: 27697439 DOI: 10.1016/j.ajem.2016.09.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
3 Collins-Yoder A, Collins RE. Periprocedural Considerations for Anticoagulated Atrial Fibrillation Patients. J Perianesth Nurs 2019;34:227-39. [PMID: 30245032 DOI: 10.1016/j.jopan.2018.05.014] [Reference Citation Analysis]
4 Generalova D, Cunningham S, Leslie SJ, Rushworth GF, Mciver L, Stewart D. Prescribers' perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation. Pharm Pract (Granada) 2020;18:1936. [PMID: 32587643 DOI: 10.18549/PharmPract.2020.2.1936] [Reference Citation Analysis]
5 Härtig F, Poli S, Ebner M, Birschmann I, Kuhn J, Ziemann U, Häring HU, Lehmann R, Peter A, Hörber S. Monitoring of low dabigatran concentrations: diagnostic performance at clinically relevant decision thresholds. J Thromb Thrombolysis 2020;49:457-67. [PMID: 31691890 DOI: 10.1007/s11239-019-01981-z] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
6 Göndör G, Stöllberger C. Pulmonary embolism four days after interruption of therapy with rivaroxaban. Hamostaseologie 2017;37:302-6. [DOI: 10.5482/hamo-17-01-0005] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
7 Brown A, Zmich Z, Roberts A, Lipof J, Judd KT. Expedited surgery in geriatric hip fracture patients taking direct oral anticoagulants is not associated with increased short-term complications or mortality rates. OTA Int 2020;3:e089. [PMID: 33937710 DOI: 10.1097/OI9.0000000000000089] [Reference Citation Analysis]
8 Park BE, Bae MH, Kim HJ, Park YJ, Kim HN, Jang SY, Lee JH, Yang DH, Park HS, Cho Y, Chae SC. Perioperative outcomes of interrupted anticoagulation in patients with non-valvular atrial fibrillation undergoing non-cardiac surgery. Yeungnam Univ J Med 2020;37:321-8. [PMID: 32668522 DOI: 10.12701/yujm.2020.00353] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Choi J, Cho SJ, Na SH, Lee A, Kim JL, Chung H, Kim SG. Use of direct oral anticoagulants does not significantly increase delayed bleeding after endoscopic submucosal dissection for early gastric neoplasms. Sci Rep 2021;11:9399. [PMID: 33931685 DOI: 10.1038/s41598-021-88656-z] [Reference Citation Analysis]
10 Milling TJ Jr, Kaatz S. Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents. Am J Med 2016;129:S80-8. [PMID: 27575436 DOI: 10.1016/j.amjmed.2016.06.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]